Work

Combining varenicline preloading with Acceptance and Commitment Therapy (ACT) in persons with serious mental illness who smoke: The randomized ACTSLow pilot feasibility trial

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2023.111012

Authors: Robert M. Anthenelli, Benjamin S. McKenna, Jillian Giannini, Saisantosh V. Attaluri, Matine Rubin, Erin O’Crowley, Sierra Miller, Jaimee L. Heffner

Institutions: University of California San Diego, VA San Diego Healthcare System, Fred Hutch Cancer Center

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Tobacco-Related Disease Research Program, University of California, Veterans Medical Research Foundation, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Cancer Institute

Awards: G1067525487, G1208509752, G125357309, G1307905518, G3548655726, G4600644026, G5997999277, Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction, ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation, 2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

OpenAlex ID: W4388024272

FWCI: 0.288

Cites: 37

Cited by: 2

Related to: 10